LIBETTE 12,5 MG COM REV CT BL AL AL X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004315850033 -
GGREM
508026080211007 -
Código de barras
7891317052621
O que a fonte publica
- Detentor do registro
- EUROFARMA LABORATORIOS S.A.
- Princípios ativos
- BENZOATO DE ALOGLIPTINA
- Embalagem
- 12,5 MG COM REV CT BL AL AL X 60
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "LIBETTE 12,5 MG COM REV CT BL AL AL X 60",
"holder": "EUROFARMA LABORATORIOS S.A.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891317052621"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "508026080211007",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.190.096/0001-92",
"priceRegime": "Regulado",
"productName": "LIBETTE",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "12,5 MG COM REV CT BL AL AL X 60",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "204.67",
"icms-12": "232.58",
"icms-17": "246.59",
"icms-18": "249.60",
"icms-19": "252.68",
"icms-20": "255.84",
"icms-21": "259.08",
"icms-22": "262.40",
"icms-23": "265.81",
"icms-17.5": "248.08",
"icms-19.5": "254.25",
"icms-20.5": "257.45",
"icms-22.5": "264.09",
"icms-12-alc": "207.66",
"icms-17-alc": "220.17",
"icms-18-alc": "222.85",
"icms-19-alc": "225.61",
"icms-20-alc": "228.43",
"icms-21-alc": "231.32",
"icms-22-alc": "234.28",
"icms-23-alc": "237.33",
"withoutTaxes": "182.74",
"icms-17.5-alc": "221.50",
"icms-19.5-alc": "227.01",
"icms-20.5-alc": "229.86",
"icms-22.5-alc": "235.79"
},
"pisCofinsList": "Negativa",
"substanceText": "BENZOATO DE ALOGLIPTINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "274.56",
"icms-12": "312.00",
"icms-17": "330.79",
"icms-18": "334.83",
"icms-19": "338.96",
"icms-20": "343.20",
"icms-21": "347.55",
"icms-22": "352.00",
"icms-23": "356.57",
"icms-17.5": "332.79",
"icms-19.5": "341.07",
"icms-20.5": "345.36",
"icms-22.5": "354.27",
"icms-12-alc": "287.08",
"icms-17-alc": "304.37",
"icms-18-alc": "308.08",
"icms-19-alc": "311.89",
"icms-20-alc": "315.79",
"icms-21-alc": "319.79",
"icms-22-alc": "323.88",
"icms-23-alc": "328.09",
"withoutTaxes": "252.63",
"icms-17.5-alc": "306.21",
"icms-19.5-alc": "313.83",
"icms-20.5-alc": "317.77",
"icms-22.5-alc": "325.97"
},
"invalidBarcodes": [],
"activeSubstances": [
"BENZOATO DE ALOGLIPTINA"
],
"therapeuticClass": "A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004315850033",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10N1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:508026080211007"